Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

WGRX vs CVS vs MCK vs CAH vs UNH

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
WGRX
Wellgistics Health, Inc.

Medical - Distribution

HealthcareNASDAQ • US
Market Cap$8M
5Y Perf.-96.9%
CVS
CVS Health Corporation

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$115.54B
5Y Perf.+37.8%
MCK
McKesson Corporation

Medical - Distribution

HealthcareNYSE • US
Market Cap$90.21B
5Y Perf.+15.0%
CAH
Cardinal Health, Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$43.22B
5Y Perf.+41.8%
UNH
UnitedHealth Group Incorporated

Medical - Healthcare Plans

HealthcareNYSE • US
Market Cap$344.90B
5Y Perf.-20.0%

WGRX vs CVS vs MCK vs CAH vs UNH — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
WGRX logoWGRX
CVS logoCVS
MCK logoMCK
CAH logoCAH
UNH logoUNH
IndustryMedical - DistributionMedical - Healthcare PlansMedical - DistributionMedical - DistributionMedical - Healthcare Plans
Market Cap$8M$115.54B$90.21B$43.22B$344.90B
Revenue (TTM)$6M$407.90B$403.43B$250.55B$449.71B
Net Income (TTM)$-73M$2.93B$4.76B$1.56B$12.04B
Gross Margin4.1%13.9%3.6%3.7%18.8%
Operating Margin-12.1%1.5%1.5%0.9%4.2%
Forward P/E12.4x16.7x17.1x20.7x
Total Debt$25M$93.59B$8.61B$9.35B$78.39B
Cash & Equiv.$1M$8.51B$3.98B$3.87B$24.36B

WGRX vs CVS vs MCK vs CAH vs UNHLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

WGRX
CVS
MCK
CAH
UNH
StockFeb 25May 26Return
Wellgistics Health,… (WGRX)1003.1-96.9%
CVS Health Corporat… (CVS)100137.8+37.8%
McKesson Corporation (MCK)100115.0+15.0%
Cardinal Health, In… (CAH)100141.8+41.8%
UnitedHealth Group … (UNH)10080.0-20.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: WGRX vs CVS vs MCK vs CAH vs UNH

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: CVS leads in 3 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and dividend income and shareholder returns. McKesson Corporation is the stronger pick specifically for growth and revenue expansion and operational efficiency and capital deployment. CAH and UNH also each lead in at least one category. As sector peers, any of these can serve as alternatives in the same allocation.
WGRX
Wellgistics Health, Inc.
The Healthcare Pick

Among these 5 stocks, WGRX doesn't own a clear edge in any measured category.

Best for: healthcare exposure
CVS
CVS Health Corporation
The Insurance Pick

CVS carries the broadest edge in this set and is the clearest fit for value and dividends.

  • Lower P/E (12.4x vs 20.7x)
  • 3.0% yield, vs UNH's 2.3%, (1 stock pays no dividend)
  • +37.4% vs WGRX's -97.2%
Best for: value and dividends
MCK
McKesson Corporation
The Growth Play

MCK is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.

  • Rev growth 12.4%, EPS growth 49.2%, 3Y rev CAGR 13.4%
  • 339.0% 10Y total return vs CAH's 158.8%
  • 12.4% revenue growth vs WGRX's -91.8%
  • 5.7% ROA vs WGRX's -138.4%, ROIC 74.5% vs -32.2%
Best for: growth exposure and long-term compounding
CAH
Cardinal Health, Inc.
The Defensive Pick

CAH ranks third and is worth considering specifically for sleep-well-at-night and defensive.

  • Lower volatility, beta 0.01, current ratio 0.94x
  • Beta 0.01, yield 1.1%, current ratio 0.94x
  • Beta 0.01 vs WGRX's 0.99
Best for: sleep-well-at-night and defensive
UNH
UnitedHealth Group Incorporated
The Insurance Pick

UNH is the clearest fit if your priority is income & stability.

  • Dividend streak 25 yrs, beta 0.60, yield 2.3%
  • 2.7% margin vs WGRX's -13.0%
Best for: income & stability
See the full category breakdown
CategoryWinnerWhy
GrowthMCK logoMCK12.4% revenue growth vs WGRX's -91.8%
ValueCVS logoCVSLower P/E (12.4x vs 20.7x)
Quality / MarginsUNH logoUNH2.7% margin vs WGRX's -13.0%
Stability / SafetyCAH logoCAHBeta 0.01 vs WGRX's 0.99
DividendsCVS logoCVS3.0% yield, vs UNH's 2.3%, (1 stock pays no dividend)
Momentum (1Y)CVS logoCVS+37.4% vs WGRX's -97.2%
Efficiency (ROA)MCK logoMCK5.7% ROA vs WGRX's -138.4%, ROIC 74.5% vs -32.2%

WGRX vs CVS vs MCK vs CAH vs UNH — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

WGRXWellgistics Health, Inc.
FY 2024
Product
100.0%$18M
CVSCVS Health Corporation
FY 2025
Pharmacy Revenue
58.9%$229.0B
Premiums
34.6%$134.8B
Front Store Revenue
5.5%$21.5B
Product and Service, Other
1.0%$3.9B
MCKMcKesson Corporation
FY 2026
North American Pharmaceutical Segment
83.4%$336.7B
Oncology And Multispecialty Segment
12.0%$48.4B
Medical-Surgical Solutions Segment
2.9%$11.5B
Prescription Technology Solutions Segment
1.4%$5.8B
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment
0.3%$1.0B
CAHCardinal Health, Inc.
FY 2025
Pharmaceutical Member
91.9%$204.6B
GMPD
5.7%$12.6B
Other Operating Segment
2.4%$5.4B
UNHUnitedHealth Group Incorporated
FY 2025
Unitedhealthcare
94.4%$332.4B
Optumhealth
5.6%$19.8B

WGRX vs CVS vs MCK vs CAH vs UNH — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLMCKLAGGINGCAH

Income & Cash Flow (Last 12 Months)

UNH leads this category, winning 4 of 6 comparable metrics.

UNH is the larger business by revenue, generating $449.7B annually — 80034.4x WGRX's $6M. UNH is the more profitable business, keeping 2.7% of every revenue dollar as net income compared to WGRX's -13.0%. On growth, CAH holds the edge at +11.0% YoY revenue growth, suggesting stronger near-term business momentum.

MetricWGRX logoWGRXWellgistics Healt…CVS logoCVSCVS Health Corpor…MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …UNH logoUNHUnitedHealth Grou…
RevenueTrailing 12 months$6M$407.9B$403.4B$250.5B$449.7B
EBITDAEarnings before interest/tax-$65M$10.5B$6.8B$3.2B$23.2B
Net IncomeAfter-tax profit-$73M$2.9B$4.8B$1.6B$12.0B
Free Cash FlowCash after capex-$7M$7.4B$6.0B$4.4B$19.7B
Gross MarginGross profit ÷ Revenue+4.1%+13.9%+3.6%+3.7%+18.8%
Operating MarginEBIT ÷ Revenue-12.1%+1.5%+1.5%+0.9%+4.2%
Net MarginNet income ÷ Revenue-13.0%+0.7%+1.2%+0.6%+2.7%
FCF MarginFCF ÷ Revenue-130.5%+1.8%+1.5%+1.8%+4.4%
Rev. Growth (YoY)Latest quarter vs prior year-80.9%+6.2%+6.0%+11.0%+2.0%
EPS Growth (YoY)Latest quarter vs prior year-11.8%+63.1%+37.0%-19.5%+0.7%
UNH leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

Evenly matched — WGRX and CVS each lead in 2 of 6 comparable metrics.

At 19.2x trailing earnings, MCK trades at a 71% valuation discount to CVS's 65.1x P/E. On an enterprise value basis, CVS's 13.4x EV/EBITDA is more attractive than UNH's 17.1x.

MetricWGRX logoWGRXWellgistics Healt…CVS logoCVSCVS Health Corpor…MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …UNH logoUNHUnitedHealth Grou…
Market CapShares × price$8M$115.5B$90.2B$43.2B$344.9B
Enterprise ValueMkt cap + debt − cash$32M$200.6B$94.9B$48.7B$398.9B
Trailing P/EPrice ÷ TTM EPS-0.65x65.14x19.19x28.47x28.72x
Forward P/EPrice ÷ next-FY EPS est.12.39x16.66x17.09x20.71x
PEG RatioP/E ÷ EPS growth rate0.43x
EV / EBITDAEnterprise value multiple13.38x15.27x15.88x17.10x
Price / SalesMarket cap ÷ Revenue0.42x0.29x0.22x0.19x0.77x
Price / BookPrice ÷ Book value/share0.65x1.53x11.63x3.40x
Price / FCFMarket cap ÷ FCF14.80x14.66x23.36x21.46x
Evenly matched — WGRX and CVS each lead in 2 of 6 comparable metrics.

Profitability & Efficiency

MCK leads this category, winning 5 of 9 comparable metrics.

MCK delivers a 3.0% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-11 for WGRX. UNH carries lower financial leverage with a 0.77x debt-to-equity ratio, signaling a more conservative balance sheet compared to WGRX's 3.73x. On the Piotroski fundamental quality scale (0–9), MCK scores 7/9 vs CVS's 5/9, reflecting strong financial health.

MetricWGRX logoWGRXWellgistics Healt…CVS logoCVSCVS Health Corpor…MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …UNH logoUNHUnitedHealth Grou…
ROE (TTM)Return on equity-10.8%+3.9%+3.0%+11.5%
ROA (TTM)Return on assets-138.4%+1.1%+5.7%+2.8%+3.9%
ROICReturn on invested capital-32.2%+5.0%+74.5%+33.8%+9.2%
ROCEReturn on capital employed-73.4%+6.1%+43.1%+19.2%+9.7%
Piotroski ScoreFundamental quality 0–965766
Debt / EquityFinancial leverage3.73x1.24x1.10x0.77x
Net DebtTotal debt minus cash$24M$85.1B$4.6B$5.5B$54.0B
Cash & Equiv.Liquid assets$1M$8.5B$4.0B$3.9B$24.4B
Total DebtShort + long-term debt$25M$93.6B$8.6B$9.3B$78.4B
Interest CoverageEBIT ÷ Interest expense-10.95x2.11x33.79x6.38x4.71x
MCK leads this category, winning 5 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — CVS and MCK and CAH each lead in 2 of 6 comparable metrics.

A $10,000 investment in MCK five years ago would be worth $37,043 today (with dividends reinvested), compared to $221 for WGRX. Over the past 12 months, CVS leads with a +37.4% total return vs WGRX's -97.2%. The 3-year compound annual growth rate (CAGR) favors CAH at 31.1% vs WGRX's -71.9% — a key indicator of consistent wealth creation.

MetricWGRX logoWGRXWellgistics Healt…CVS logoCVSCVS Health Corpor…MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …UNH logoUNHUnitedHealth Grou…
YTD ReturnYear-to-date-80.6%+14.7%-10.5%-10.2%+13.6%
1-Year ReturnPast 12 months-97.2%+37.4%+7.2%+26.1%+0.8%
3-Year ReturnCumulative with dividends-97.8%+41.2%+102.1%+125.5%-17.8%
5-Year ReturnCumulative with dividends-97.8%+19.8%+270.4%+232.0%-0.9%
10-Year ReturnCumulative with dividends-97.8%+6.6%+339.0%+158.8%+228.3%
CAGR (3Y)Annualised 3-year return-71.9%+12.2%+26.4%+31.1%-6.3%
Evenly matched — CVS and MCK and CAH each lead in 2 of 6 comparable metrics.

Risk & Volatility

Evenly matched — CVS and MCK each lead in 1 of 2 comparable metrics.

MCK is the less volatile stock with a -0.02 beta — it tends to amplify market swings less than WGRX's 0.99 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CVS currently trades 99.6% from its 52-week high vs WGRX's 1.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricWGRX logoWGRXWellgistics Healt…CVS logoCVSCVS Health Corpor…MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …UNH logoUNHUnitedHealth Grou…
Beta (5Y)Sensitivity to S&P 5000.99x0.13x-0.02x0.01x0.60x
52-Week HighHighest price in past year$7.04$90.88$999.00$233.60$390.92
52-Week LowLowest price in past year$0.08$58.35$637.00$137.75$234.60
% of 52W HighCurrent price vs 52-week peak+1.2%+99.6%+73.7%+78.6%+97.2%
RSI (14)Momentum oscillator 0–10029.170.021.028.676.9
Avg Volume (50D)Average daily shares traded13.8M7.5M782K1.8M7.9M
Evenly matched — CVS and MCK each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — CVS and UNH each lead in 1 of 2 comparable metrics.

Analyst consensus: CVS as "Buy", MCK as "Buy", CAH as "Buy", UNH as "Buy". Consensus price targets imply 38.0% upside for CAH (target: $253) vs 1.4% for UNH (target: $385). For income investors, CVS offers the higher dividend yield at 2.95% vs MCK's 0.42%.

MetricWGRX logoWGRXWellgistics Healt…CVS logoCVSCVS Health Corpor…MCK logoMCKMcKesson Corporat…CAH logoCAHCardinal Health, …UNH logoUNHUnitedHealth Grou…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuy
Price TargetConsensus 12-month target$96.75$994.86$253.38$385.43
# AnalystsCovering analysts41313352
Dividend YieldAnnual dividend ÷ price+3.0%+0.4%+1.1%+2.3%
Dividend StreakConsecutive years of raises0182025
Dividend / ShareAnnual DPS$2.67$3.07$2.04$8.70
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%0.0%+1.8%+1.6%
Evenly matched — CVS and UNH each lead in 1 of 2 comparable metrics.
Key Takeaway

UNH leads in 1 of 6 categories (Income & Cash Flow). MCK leads in 1 (Profitability & Efficiency). 4 tied.

Best OverallMcKesson Corporation (MCK)Leads 1 of 6 categories
Loading custom metrics...

WGRX vs CVS vs MCK vs CAH vs UNH: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is WGRX or CVS or MCK or CAH or UNH a better buy right now?

For growth investors, McKesson Corporation (MCK) is the stronger pick with 12.

4% revenue growth year-over-year, versus -1. 9% for Cardinal Health, Inc. (CAH). McKesson Corporation (MCK) offers the better valuation at 19. 2x trailing P/E (16. 7x forward), making it the more compelling value choice. Analysts rate CVS Health Corporation (CVS) a "Buy" — based on 41 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — WGRX or CVS or MCK or CAH or UNH?

On trailing P/E, McKesson Corporation (MCK) is the cheapest at 19.

2x versus CVS Health Corporation at 65. 1x. On forward P/E, CVS Health Corporation is actually cheaper at 12. 4x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — WGRX or CVS or MCK or CAH or UNH?

Over the past 5 years, McKesson Corporation (MCK) delivered a total return of +270.

4%, compared to -97. 8% for Wellgistics Health, Inc. (WGRX). Over 10 years, the gap is even starker: MCK returned +339. 0% versus WGRX's -97. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — WGRX or CVS or MCK or CAH or UNH?

By beta (market sensitivity over 5 years), McKesson Corporation (MCK) is the lower-risk stock at -0.

02β versus Wellgistics Health, Inc. 's 0. 99β — meaning WGRX is approximately -6128% more volatile than MCK relative to the S&P 500. On balance sheet safety, UnitedHealth Group Incorporated (UNH) carries a lower debt/equity ratio of 77% versus 4% for Wellgistics Health, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — WGRX or CVS or MCK or CAH or UNH?

By revenue growth (latest reported year), McKesson Corporation (MCK) is pulling ahead at 12.

4% versus -1. 9% for Cardinal Health, Inc. (CAH). On earnings-per-share growth, the picture is similar: Cardinal Health, Inc. grew EPS 87. 0% year-over-year, compared to -116. 7% for Wellgistics Health, Inc.. Over a 3-year CAGR, MCK leads at 13. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — WGRX or CVS or MCK or CAH or UNH?

UnitedHealth Group Incorporated (UNH) is the more profitable company, earning 2.

7% net margin versus -37. 8% for Wellgistics Health, Inc. — meaning it keeps 2. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: UNH leads at 4. 2% versus -33. 9% for WGRX. At the gross margin level — before operating expenses — UNH leads at 18. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is WGRX or CVS or MCK or CAH or UNH more undervalued right now?

On forward earnings alone, CVS Health Corporation (CVS) trades at 12.

4x forward P/E versus 20. 7x for UnitedHealth Group Incorporated — 8. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CAH: 38. 0% to $253. 38.

08

Which pays a better dividend — WGRX or CVS or MCK or CAH or UNH?

In this comparison, CVS (3.

0% yield), UNH (2. 3% yield), CAH (1. 1% yield), MCK (0. 4% yield) pay a dividend. WGRX does not pay a meaningful dividend and should not be held primarily for income.

09

Is WGRX or CVS or MCK or CAH or UNH better for a retirement portfolio?

For long-horizon retirement investors, Cardinal Health, Inc.

(CAH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 01), 1. 1% yield, +158. 8% 10Y return). Both have compounded well over 10 years (CAH: +158. 8%, WGRX: -97. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between WGRX and CVS and MCK and CAH and UNH?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

CVS, CAH, UNH pay a dividend while WGRX, MCK do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

WGRX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

CVS

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 1.1%
Run This Screen
Stocks Like

MCK

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

CAH

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

UNH

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Dividend Yield > 0.9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform WGRX and CVS and MCK and CAH and UNH on the metrics below

Revenue Growth>
%
(WGRX: -80.9% · CVS: 6.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.